X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.gilead.com/news-and-press/press-room/press-releases/2024/4/gilead-sciences-announces-first-quarter-2024-financial-results
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217037
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-bictegravir-sodium-emtricitabine-and-tenofovir-alafenamide-fumarate-tablets-80375.pdf
https://www.biospace.com/article/gilead-wins-hiv-patent-suit-nabs-oncology-and-inflammation-startup/?s=79
https://www.reuters.com/business/healthcare-pharmaceuticals/gilead-us-square-off-billion-dollar-hiv-drug-patent-trial-2023-05-02/
https://www.fiercepharma.com/marketing/dovato-advert-dispute-between-viiv-and-gilead-escalates-feds-after-self-regulatory
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211640
https://www.reuters.com/business/healthcare-pharmaceuticals/gsks-viiv-says-study-shows-its-long-acting-hiv-shot-effective-gileads-daily-pill-2023-02-22/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-tentative-usfda-nod-for-dolutegravir-emtricitabine-and-tenofovir-alafenamide-tablets/articleshow/97482041.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214544
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216875
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-emtricitabine-and-tenofovir-alafenamide-fumarate-tablets-96673.pdf
https://endpts.com/federal-claims-court-rules-in-favor-of-gilead-in-cdc-truvada-patent-case/
https://www.pharmaceutical-technology.com/news/gilead-ec-hiv-treatment/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214058
https://www.fool.com/investing/2022/09/14/my-biggest-worry-about-gilead-sciences/
https://www.fiercepharma.com/pharma/gilead-cant-escape-antitrust-suit-centered-pay-delay-deal-cipla-judge-says
https://www.fiercepharma.com/pharma/gilead-pads-case-top-seller-biktarvy-hivhepatitis-b-coinfection
https://endpts.com/gilead-says-a-network-of-suppliers-and-distributors-sold-tens-of-thousands-of-fake-versions-of-its-hiv-meds/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201806
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-symtuza-210455-darunavir-cobicistat-emtricitabine-tenofovir-alefenamide-80mg-150mg-200mg-10mg-tablets-1633682776.pdf
https://www.fiercepharma.com/pharma/gilead-merck-and-others-slapped-pay-for-delay-lawsuits-over-lucrative-hiv-and-cholesterol
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204287
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204287
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204131
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208740
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208740
https://www.business-standard.com/article/news-cm/strides-receives-usfda-approval-for-emtricitabine-and-tenofovir-disoproxil-fumarate-tablets-121011500225_1.html
https://www.businesswire.com/news/home/20201201005450/en/Gilead-Canada-Announces-Notice-of-Compliance-for-DESCOVY%C2%AE-emtricitabine-tenofovir-alafenamide-for-HIV-Pre-Exposure-Prophylaxis-PrEP
https://www.fiercepharma.com/marketing/gsk-s-hiv-prep-challenge-looms-as-viiv-s-long-acting-drug-tops-gilead-s-truvada-women
https://www.fiercepharma.com/manufacturing/gilead-sciences-truvada-will-face-teva-generic-challenger-amid-descovy-switching
https://www.newswise.com/articles/common-hiv-drugs-increase-a-type-of-immunity-in-the-gut
https://www.fiercepharma.com/marketing/gilead-slammed-for-misleading-claim-biktarvy-against-gsk-s-rival-hiv-drug
https://www.statnews.com/2018/08/29/larry-kramer-aids-gilead-nih-fda/
http://www.pharmatimes.com/news/viiv_hiv_prevention_trial_stopped_early_on_efficacy_1340441
https://www.fiercepharma.com/marketing/more-threat-to-gilead-s-hiv-business-gsk-touts-long-acting-injectable-prep-win-against
https://www.statnews.com/pharmalot/2020/04/26/gilead-cdc-lawsuit-hiv-research-truvada/
https://www.fiercepharma.com/special-report/top-10-drugs-losing-u-s-exclusivity-2020
https://www.fiercepharma.com/pharma/gilead-s-descovy-not-worth-higher-price-over-forthcoming-truvada-generics-study
https://lfpress.com/pmn/health-pmn/misleading-ads-turn-people-away-from-hiv-prevention-meds/wcm/d3721612-b7aa-48c9-835e-35ab35fdfd20
http://www.pharmabiz.com/NewsDetails.aspx?aid=120660&sid=1
Market Place
Share 
